Trademark: Nordic Nanovector 1734109
Word
Nordic Nanovector
ID
1734109
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
02 September 2015
Registration Date
02 September 2015
Renewal Date
02 September 2025
Owner(s)
Service
Goods and Services:
Class 5:
Pharmaceutical preparations and substances, including pharmaceutical preparations and substances for use in hematology, oncology and for the treatment of cancer; reagents for medical use; medical diagnostic chemicals and medical diagnostic reagents for medical use; antibody-based chemicals and reagents for medical use, namely, monoclonal antibodies, immuno-radiotherapies, antibody-radionuclide-conjugates; radiotherapies; diagnostic assay test kits for medical use consisting of medical diagnostic chemicals and reagents; biochemical preparations, namely antibodies for medical diagnostic and therapeutic use
Pharmaceutical preparations and substances, including pharmaceutical preparations and substances for use in hematology, oncology and for the treatment of cancer; reagents for medical use; medical diagnostic chemicals and medical diagnostic reagents for medical use; antibody-based chemicals and reagents for medical use, namely, monoclonal antibodies, immuno-radiotherapies, antibody-radionuclide-conjugates; radiotherapies; diagnostic assay test kits for medical use consisting of medical diagnostic chemicals and reagents; biochemical preparations, namely antibodies for medical diagnostic and therapeutic use
Class 42:
Medical and pharmaceutical research and development, including medical and pharmaceutical research and development in the field of hematology, oncology and the treatment of cancer; conducting clinical trials, including conducting clinical trials in the field of hematology, oncology and the treatment of cancer; providing medical research and scientific research information, including in the field of hematology, oncology and the treatment of cancer
Medical and pharmaceutical research and development, including medical and pharmaceutical research and development in the field of hematology, oncology and the treatment of cancer; conducting clinical trials, including conducting clinical trials in the field of hematology, oncology and the treatment of cancer; providing medical research and scientific research information, including in the field of hematology, oncology and the treatment of cancer